Funder
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Pharmacology
Reference50 articles.
1. Crime. UNODC World Drug Report. https://www.unodc.org/unodc/data-and-analysis/world-drug-report-2022.html. 2022.
2. Florence C, Luo F, Rice K. The economic burden of opioid use disorder and fatal opioid overdose in the United States, 2017. Drug Alcohol Depend. 2021;218:108350.
3. SAMHSA, Key substance use and mental health indicators in the united states: Results from the 2021 national survey on drug use and health (HHS Publication No. PEP22-07-01-005, NSDUH Series H-57), Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration; 2022. Retrieved from https://www.samhsa.gov/data/.
4. O’Brien CP. Anticraving medications for relapse prevention: a possible new class of psychoactive medications. Am J Psychiatry. 2005;162:1423–31.
5. Elkashef A, Biswas J, Acri JB, Vocci F. Biotechnology and the treatment of addictive disorders: new opportunities. BioDrugs. 2007;21:259–67.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献